NYSE:WAT - Waters Stock Price, News & Analysis

Waters trades on the New York Stock Exchange (NYSE) under the ticker symbol "WAT."

Waters declared that its Board of Directors has initiated a stock repurchase plan on Tuesday, April 24th 2018, which authorizes the company to repurchase $3,000,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to buy up to 18.2% of its stock through open market purchases. Stock repurchase plans are often an indication that the company's management believes its stock is undervalued.

Waters Co. (NYSE:WAT) issued its earnings results on Tuesday, July, 30th. The medical instruments supplier reported $2.14 EPS for the quarter, topping analysts' consensus estimates of $2.11 by $0.03. The medical instruments supplier earned $599.20 million during the quarter, compared to analyst estimates of $601.46 million. Waters had a net margin of 24.09% and a return on equity of 50.64%. The company's revenue for the quarter was up .5% compared to the same quarter last year. During the same period last year, the firm posted $1.95 EPS. View Waters' Earnings History.

Waters is scheduled to release their next quarterly earnings announcement on Tuesday, October 22nd 2019. View Earnings Estimates for Waters.

Waters updated its FY19 earnings guidance on Tuesday, July, 30th. The company provided EPS guidance of $8.95-9.10 for the period, compared to the Thomson Reuters consensus EPS estimate of $9.08.

12 analysts have issued 12 month target prices for Waters' shares. Their forecasts range from $177.00 to $260.00. On average, they expect Waters' stock price to reach $209.7288 in the next twelve months. This suggests that the stock has a possible downside of 0.1%. View Analyst Price Targets for Waters.

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Waters in the last year. There are currently 5 sell ratings, 6 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Waters.

News coverage about WAT stock has trended positive on Thursday, according to InfoTrie. The research firm ranks the sentiment of press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Waters earned a media sentiment score of 2.5 on InfoTrie's scale. They also assigned press coverage about the medical instruments supplier a news buzz of 6.0 out of 10, meaning that recent press coverage is somewhat likely to have an effect on the company's share price in the next few days. View News Stories for Waters.

Waters saw a increase in short interest in July. As of July 31st, there was short interest totalling 4,186,200 shares, an increase of 8.4% from the June 30th total of 3,862,000 shares. Based on an average daily volume of 595,600 shares, the days-to-cover ratio is currently 7.0 days. Currently, 6.2% of the shares of the company are sold short. View Waters' Current Options Chain.

Some companies that are related to Waters include Illumina (ILMN), Agilent Technologies (A), Mettler-Toledo International (MTD), Bio-Rad Laboratories (BIO), Bio-Rad Laboratories (BIO.B), Avantor (AVTR), PerkinElmer (PKI), Bruker (BRKR), Coherent (COHR), Horiba (HRIBF), Accelerate Diagnostics (AXDX), Pacific Biosciences of California (PACB), Quanterix (QTRX), Fluidigm (FLDM) and Eyepoint Pharmaceuticals (EYPT).

Based on aggregate information from My MarketBeat watchlists, some companies that other Waters investors own include Thermo Fisher Scientific (TMO), Home Depot (HD), Honeywell International (HON), Alibaba Group (BABA), Raytheon (RTN), Verizon Communications (VZ), Cisco Systems (CSCO), Johnson & Johnson (JNJ), UnitedHealth Group (UNH) and Northrop Grumman (NOC).

Waters' stock is owned by a number of of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (11.40%), BlackRock Inc. (8.03%), Bank of New York Mellon Corp (6.36%), Baillie Gifford & Co. (3.75%), Janus Henderson Group PLC (2.45%) and Janus Henderson Group PLC (2.55%). Company insiders that own Waters stock include Christopher A Kuebler, David Terricciano, Elizabeth B Rae, Eugene G Cassis, Joann A Reed, Mark T Beaudouin, Michael C Harrington, Michael F Silveira, Michael J Berendt, Robert G Carson, Rohit Khanna, Terrence P Kelly, Thomas P Salice and William J Miller. View Institutional Ownership Trends for Waters.

WAT stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Bank of America Corp DE, Morgan Stanley, Janus Henderson Group PLC, Janus Henderson Group PLC, Pictet Asset Management Ltd., Pictet Asset Management Ltd. and Renaissance Technologies LLC. Company insiders that have sold Waters company stock in the last year include Christopher A Kuebler, Elizabeth B Rae, Mark T Beaudouin, Michael C Harrington, Michael F Silveira, Michael J Berendt, Robert G Carson, Terrence P Kelly and Thomas P Salice. View Insider Buying and Selling for Waters.

WAT stock was bought by a variety of institutional investors in the last quarter, including Mackenzie Financial Corp, Nuveen Asset Management LLC, Invesco Ltd., Wells Fargo & Company MN, Ontario Teachers Pension Plan Board, Schroder Investment Management Group, Impax Asset Management Group plc and First Trust Advisors LP. View Insider Buying and Selling for Waters.

Shares of WAT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of WAT stock can currently be purchased for approximately $209.99.

Waters has a market capitalization of $14.02 billion and generates $2.42 billion in revenue each year. The medical instruments supplier earns $593.79 million in net income (profit) each year or $8.29 on an earnings per share basis. Waters employs 7,200 workers across the globe.View Additional Information About Waters.

The official website for Waters is http://www.waters.com/.

Waters' mailing address is 34 MAPLE STREET, MILFORD MA, 01757. The medical instruments supplier can be reached via phone at 508-478-2000 or via email at [email protected]